D&CVD Publications

Winner Abstract "International School of Diabetes": SGLT2 inhibitors to target prediabetes in adults: a randomised, double- blind, placebo-controlled, parallel-group, proof-of-concept study

Beccuti G

 

Report from the 3rd Cardiovascular Outcome Trial (CVOT) Summit of the Diabetes & Cardiovascular Disease (D&CVD)EASD Study Group

Schnell O, Standl E, Catrinoiu D, Genovese S, Lalic N, Lalic K, Skrha J, Valensi P, Ceriello A
Cardiovasc Diabetol. 2018 17:30 doi: 10.1186/s12933-018-0667-2.

 

Updates on Cardiovascular Outcome Trials in Diabetes

Schnell O, Rydén L, Standl E, Ceriello A and on behalf of the D&CVD EASD Study Group
Cardiovascular Diabetology 2017 16:128 doi: 10.1186/s12933-017-0610-y

 

Report from the 2nd Cardiovascular Outcome Trial (CVOT) Summit of the Diabetes & Cardiovascular Disease (D&CVD) EASD Study Group.

Schnell O, Standl E, Catrinoiu D, Genovese S, Lalic N, Skrha J, Valensi P, Rahelic D, Ceriello A
Cardiovasc Diabetol. 2017 18;16:35. doi: 10.1186/s12933-017-0508-x.

 

Current perspectives on cardiovascular outcome trials in diabetes.

Schnell O, Rydén L, Standl E, Ceriello A
Cardiovasc Diabetol. 2016 Oct 1;15(1):139.

 

Report from the 1st Cardiovascular Outcome Trial (CVOT) Summit of the Diabetes & Cardiovascular Disease (D&CVD) EASD Study Group.

Schnell O, Standl E, Catrinoiu D, Genovese S, Lalic N, Skra J, Valensi P, Ceriello A
Cardiovasc Diabetol. 2016 Feb 18;15:33. doi: 10.1186/s12933-016-0357-x.

 

Type 1 diabetes and cardiovascular disease

Schnell O, Cappuccio F, Genovese S, Standl E, Valensi P, Ceriello A
Cardiovascular Diabetology 2013, 12: 156